Governance of the clinical pathway and management of the patient suffering from epilepsy and drug-resistant epilepsy [0.03%]
癫痫及药物难治性癫痫临床路径的管理规范以及患者管理
Angela La Neve,Giovanni Falcicchio
Angela La Neve
Epilepsy is a diffuse chronic neurological disease affecting around 50 million people worldwide. The diagnostic criteria by the International League against Epilepsy must be fulfilled to diagnose the disease, which is characterized by brief...
Dieci priorità nel trattamento del paziente con sindrome coronarica acuta [0.03%]
急性冠状动脉综合征患者治疗的十大重点
Giovanni Esposito,Fabrizio Ricci,Giovanni Battista Zito
Giovanni Esposito
La gestione a lungo termine del paziente a rischio: territorio e ospedale, ruolo e sinergie [0.03%]
长期高危患者的管理：区域和医院的作用与协同效应
Giovanni Battista Zito
Giovanni Battista Zito
Giovanni Esposito,Fabrizio Ricci,Giovanni Battista Zito
Giovanni Esposito
Approccio diagnostico e terapeutico al paziente con sindrome coronarica acuta [0.03%]
急性冠状动脉综合征患者的诊断和治疗方案
Fabrizio Ricci,Federico Archilletti,Raffaele De Caterina
Fabrizio Ricci
Opportunità cliniche e impatto sul sistema sanitario di un trattamento ottimale del paziente post-sindrome coronarica acuta [0.03%]
急性冠状动脉综合征后患者优化治疗的临床机遇及对医疗卫生系统的影响
Giuseppe Gargiulo,Giovanni Esposito
Giuseppe Gargiulo
Analisi di budget impact di anakinra nel trattamento della Malattia di Still in Italia [0.03%]
在意大利斯蒂尔病治疗中对阿那白滞素预算影响分析
Roberto Ravasio,Roberto Giacomelli,Stefano Bianchi
Roberto Ravasio
Towards standardization of economic evaluation research in the youth psychosocial care sector: A broad consultation in the Netherlands [0.03%]
朝着荷兰青年心理社会护理领域经济评价研究标准化努力：一次广泛的咨询活动
Silvia M A A Evers,Carmen D Dirksen
Silvia M A A Evers
Introduction: Stakeholders are increasingly interested in the societal impact of psychosocial interventions in the youth sector, in terms of costs and quality of life, as well as in outcomes research. The aim of this broa...
Cost-effectiveness and budget impact of a lifestyle intervention to improve cardiometabolic health in patients with severe mental illness [0.03%]
针对严重精神疾病患者改善心肺代谢健康的 Lifestyle 干预的成本效益与预算影响分析
Anne Looijmans,Frederike Jörg,Richard Bruggeman et al.
Anne Looijmans et al.
Introduction: This study assessed the cost-effectiveness and budget impact of a lifestyle intervention to improve cardiometabolic health in severe mentally ill (SMI) patients in the LION trial. ...
L’impatto della cross-copertura di dupilumab sulla spesa a carico del Servizio Sanitario Nazionale [0.03%]
dupilumab的交叉覆盖对国家卫生服务体系支出的影响
Claudio Jommi,Filippo Cipriani,Francesca Fanelli et al.
Claudio Jommi et al.